<?xml version="1.0" encoding="UTF-8"?>
<p id="Par90" class="p">In general, the development of new trypanocidal agents has been focused on the use of molecules that alter the cellular redox potential and take advantage of the scarce antioxidant defenses of the parasite [
 <xref ref-type="bibr" rid="CR39" class="xref">39</xref>, 
 <xref ref-type="bibr" rid="CR40" class="xref">40</xref>]. A similar anti-protozoal effect has been described for essential oils rich in terpenes extracted from aromatic plants [
 <xref ref-type="bibr" rid="CR43" class="xref">43</xref>]. In this regard, EOs derived from 
 <italic class="italic">Cymbopogon citratus</italic> showed promising results, with low IC
 <sub class="sub">50</sub> values against 
 <italic class="italic">T. cruzi</italic> (15.5 μg/mL for Epi and Tryp; and 5.1 μg/mL for Amas) [
 <xref ref-type="bibr" rid="CR17" class="xref">17</xref>]. These trypanocidal effects were attributed to the high levels of the oxygenated monoterpene citral (a mixture of neral and geranial) [
 <xref ref-type="bibr" rid="CR17" class="xref">17</xref>]. Similar outcomes were obtained with oils extracted from a Colombian (Santander) variant of 
 <italic class="italic">L. alba</italic> (Citral chemotype), which were rich in such terpenes as citral, geraniol, timol, and caryophyllene oxide [
 <xref ref-type="bibr" rid="CR30" class="xref">30</xref>].
</p>
